Skip to main content
NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%

About Prelude Therapeutics Incorporat (PRLD)

Prelude Therapeutics Incorporat (PRLD) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for PRLD on iGotFomo.

PRLD Key Statistics

0
PRLD key financial statistics
Current Price$4.50Market Cap$358 million
Daily Change+5.39%Volume367K
52-Week High$5.5452-Week Low$0.75
SectorHealthcareIndustryBiotechnology

Frequently Asked Questions About PRLD

What is Prelude Therapeutics Incorporat (PRLD)?
Prelude Therapeutics Incorporat (PRLD) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
What is the current PRLD stock price?
As of the latest trading session, PRLD trades at $4.50 per share, with a daily change of +5.39%.
What is PRLD's market capitalization?
Prelude Therapeutics Incorporat has a market capitalization of $358 million, making it a small-cap stock.
What sector does PRLD belong to?
Prelude Therapeutics Incorporat operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.